EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Acute toxicity of hypofractionated radiotherapy for Japanese breast cancer patients after surgery: a single center prospective observational study (HyPORT-BC)

Masaki Nakamura, Takeshi Fujisawa, Hidekazu Oyoshi, Yuzheng Zhou, Keiko Fukushi, Hidenari Hirata, Kento Tomizawa, Atsushi Motegi, Hidehiro Hojo, Masashi Wakabayashi, Kazuto Kano, Risa Ohno und 3 weitere

Breast Cancer · 2024-11 · 31 (6) · 1176-1181

DOI: 10.1007/s12282-024-01626-x ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Breast Cancer, online erschienen am 08.08.2024. Verfasst von Masaki Nakamura und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. masanaka@east.ncc.go.jp. Hauptthemen laut MEDLINE: Breast Neoplasms, Radiation Dose Hypofractionation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: This single center prospective observational study was conducted to evaluate the acute toxicity of hypo-fractionated radiotherapy for Japanese breast cancer patients after surgery. METHODS: This study recruited patients who were scheduled for moderately hypo-fractionated radiotherapy including supraclavicular lymph node area (Cohort M) or ultra-hypo-fractionated radiotherapy for the conserved breast (Cohort U) as postoperative treatment for breast cancer. Radiotherapy plans were generated using automated planning system. Irradiation of 42.5 Gy/16 fractions (Cohort M) or 26 Gy/5 fractions (Cohort U) was delivered, and boost irradiation of 10 Gy/5 fractions was added as needed. The primary endpoint was the proportion of grade ≥ 2 acute adverse events within 90 days. The toxicities were evaluated using CTCAE ver 5.0. RESULTS: Between January 2023 and December 2023, 123 patients (81 in Cohort M and 42 in Cohort U) were enrolled. All the included patients were Japanese and completed their planned radiotherapy and were also able to be evaluated for acute adverse events. Grade 1/2/3-5 acute adverse events were observed in 67/12/0 for Cohort M and 31/4/0 for Cohort U. The proportion of grade ≥ 2 acute adverse events within 90 days was 15% (95% confidence interval 8-24%) for Cohort M and 10% (95% confidence interval 3-23%) for Cohort U. CONCLUSIONS: The proportion of acute toxicity of hypo-fractionated radiotherapy for Japanese breast cancer patients after surgery was shown to be acceptable in this study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsRadiation Dose HypofractionationHumansFemaleMiddle AgedProspective StudiesAgedAdultJapanRadiotherapy, AdjuvantMastectomy, SegmentalAged, 80 and overEast Asian People

Stichwörter der Autor:innen

Adverse eventAutomated treatmentBreast cancerHypofractionatedRadiotherapy

Autor:innen und Institutionen

  • Department of Radiation Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. masanaka@east.ncc.go.jp.
  • Course of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo, Japan. masanaka@east.ncc.go.jp.
  • Department of Radiation Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
  • Clinical Research Support Office Biostatistics Section, National Cancer Center Hospital East, Chiba, Japan.
  • Department of Radiological Technology, National Cancer Center Hospital East, Chiba, Japan.
  • Course of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Zitieren

APA

Nakamura, M., Fujisawa, T., Oyoshi, H., Zhou, Y., Fukushi, K., Hirata, H., Tomizawa, K., Motegi, A., Hojo, H., Wakabayashi, M., Kano, K., Ohno, R., Nakamura, A., Yamaguchi, M., & Zenda, S. (2024). Acute toxicity of hypofractionated radiotherapy for Japanese breast cancer patients after surgery: a single center prospective observational study (HyPORT-BC). Breast Cancer, 31(6), 1176-1181. https://doi.org/10.1007/s12282-024-01626-x

Vancouver

Nakamura M, Fujisawa T, Oyoshi H, Zhou Y, Fukushi K, Hirata H, et al. Acute toxicity of hypofractionated radiotherapy for Japanese breast cancer patients after surgery: a single center prospective observational study (HyPORT-BC). Breast Cancer. 2024;31(6):1176-1181. doi:10.1007/s12282-024-01626-x

BibTeX
@article{Nakamura2024,
  author = {Nakamura, Masaki and Fujisawa, Takeshi and Oyoshi, Hidekazu and Zhou, Yuzheng and Fukushi, Keiko and Hirata, Hidenari and Tomizawa, Kento and Motegi, Atsushi and Hojo, Hidehiro and Wakabayashi, Masashi and Kano, Kazuto and Ohno, Risa and Nakamura, Azusa and Yamaguchi, Masayuki and Zenda, Sadamoto},
  title = {Acute toxicity of hypofractionated radiotherapy for Japanese breast cancer patients after surgery: a single center prospective observational study (HyPORT-BC)},
  journal = {Breast Cancer},
  year = {2024},
  volume = {31},
  number = {6},
  pages = {1176--1181},
  doi = {10.1007/s12282-024-01626-x}
}
Kostenlos starten →